EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
3-Stock Lunch: Palantir, MicroStrategy and Moderna
Arbutus Biopharma's SWOT analysis: hepatitis B focus drives stock potential By Investing.com
/Moderna%20Inc%20meds-by%20Ascannio%20via%20Shutterstock.jpg)
Is Moderna Stock Underperforming the Dow?
Quantinno Capital Management LP Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)
MicroStrategy, Palantir added to Nasdaq 100, with Moderna facing an exit | The Star
Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles By Investing.com
Toronto Dominion Bank Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA)
Nasdaq Inc (NDAQ) Announces Annual Reconstitution of Nasdaq-100 Index
Saylor’s MicroStrategy Scores Again With Nasdaq 100 Addition
Moderna, Inc. (NASDAQ:MRNA) Holdings Increased by Inspire Trust Co. N.A.
Public Employees Retirement System of Ohio Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Geode Capital Management LLC
Moderna, Inc. (NASDAQ:MRNA) Given Consensus Rating of "Hold" by Analysts
Moderna's SWOT analysis: stock faces transition as covid vaccine demand wanes By Investing.com
Your Guide to COVID Vaccines for 2024-2025 | MDedge
Moderna Stays Upbeat As Anti-Vaxxers Prepare To Rule In D.C. 12/12/2024
Chelsea Counsel Co. Sells 635 Shares of Moderna, Inc. (NASDAQ:MRNA)
Cancer Vaccines Market worth $20.47 billion in 2032
Moderna, Inc. (NASDAQ:MRNA) Insider Shannon Thyme Klinger Sells 529 Shares
National Bank of Canada FI Acquires 90,739 Shares of Moderna, Inc. (NASDAQ:MRNA)
Bank of America Reaffirms “Underperform” Rating for Moderna (NASDAQ:MRNA)
Pfizer stock outlook dims as 2025 EPS guidance reflects normalization of COVID business By Investing.com
Carisma Therapeutics cut to In Line, stock target slashed on tempered outlook By Investing.com
FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates - December 11, 2024 - Zacks.com
Moderna (NASDAQ:MRNA) Shares Down 5.8% – Here’s What Happened
Moderna's (MRNA) Underperform Rating Reiterated at Bank of America
Moderna’s mRNA vaccines to be exempted from advisory committee scrutiny under $2bn Morrison-era deal
Moderna officially opens new vaccine manufacturing facility in Australia
BTIG cuts Carisma Therapeutics to Neutral from Buy By Investing.com
Carisma Therapeutics shifts focus, cuts workforce by 34% By Investing.com
Carisma Therapeutics plans reduction in the workforce by 34% By Investing.com
XTX Topco Ltd Buys 25,400 Shares of Moderna, Inc. (NASDAQ:MRNA)
Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by Wellington Management Group LLP
Two Sigma Advisers LP Acquires Shares of 356,500 Moderna, Inc. (NASDAQ:MRNA)
State Street Corp Buys 1,823,276 Shares of Moderna, Inc. (NASDAQ:MRNA)
Chevy Chase Trust Holdings LLC Sells 1,028 Shares of Moderna, Inc. (NASDAQ:MRNA)
Rockefeller Capital Management L.P. Lowers Stake in Moderna, Inc. (NASDAQ:MRNA)
Moderna chief legal officer sells $4,849 in stock By Investing.com
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Lowers Position in Moderna, Inc. (NASDAQ:MRNA)
Arbutus Biopharma's SWOT analysis: focus on CHB treatment drives stock outlook By Investing.com
Moderna president Stephen Hoge sells shares worth $13,595 By Investing.com
Motley Fool Wealth Management LLC Decreases Stock Position in Moderna, Inc. (NASDAQ:MRNA)
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln
Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mn | World News - Business Standard
DexCom, Orthofix, Spire Global, and Moderna Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information | Morningstar
Moderna shares could slump over 30% on negative CMV reading: Leerink By Investing.com
Moderna shares face doubts as Leerink questions odds of success in Phase 3 CMV study By Investing.com
Moderna president Stephen Hoge sells shares worth $12,451 By Investing.com
Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now?
Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Future Challenges
Moderna CFO James Mock sells shares worth $60,760 By Investing.com
Arizona PSPRS Trust Purchases Shares of 25,100 Moderna, Inc. (NASDAQ:MRNA)
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Bellevue Group AG
MetLife Investment Management LLC Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
Moderna, Inc. (MRNA): A Bull Case Theory
Moderna, Inc. (NASDAQ:MRNA) Holdings Reduced by Northwest & Ethical Investments L.P.
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Bank of Montreal Can
Fmr LLC Has $1.16 Billion Holdings in Moderna, Inc. (NASDAQ:MRNA)
Natixis Advisors LLC Decreases Holdings in Moderna, Inc. (NASDAQ:MRNA)
Why Is Moderna, Inc. (MRNA) Among the Worst Performing Healthcare Stocks in 2024?
RBC Capital Reaffirms Their Hold Rating on Moderna (MRNA) | Markets Insider
Moderna (NASDAQ:MRNA) Price Target Cut to $45.00 by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price
CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, In
Moderna to Present at Upcoming Conferences in December 2024 | Morningstar
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Citigroup Inc.
MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights | Morningstar
Moderna, Inc. (NASDAQ:MRNA) Holdings Decreased by Mutual of America Capital Management LLC
Moderna Target of Unusually High Options Trading (NASDAQ:MRNA)
Investors Buy High Volume of Moderna Call Options (NASDAQ:MRNA)
Moderna (NASDAQ:MRNA) Stock Price Up 6.2% - Still a Buy?
MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit | Morningstar
Moderna Inc. (MRNA): Among the Most Promising Cancer Stocks According to Hedge Funds
Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock
MGX DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGX | Morningstar
DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024 | Morningstar
Banco Santander S.A. Acquires Shares of 53,115 Moderna, Inc. (NASDAQ:MRNA)
Jefferies says market nears short term “peak RFK negativity", Vaccine makers up By Investing.com
The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX | Morningstar
FY2025 EPS Estimates for Moderna Cut by Leerink Partnrs
Jefferies holds Moderna at $50 target, cites RFK concerns By Investing.com
Moderna (NASDAQ:MRNA) Stock Price Down 5% – What’s Next?
Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?
MGX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ...
Shareholders that lost money on Metagenomi, Inc. (MGX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More | Morningstar
MGX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In MGX To Contact Him Directly To Discuss Their Options | Morningstar
Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by John G Ullman & Associates Inc.
Fall Vaccine Updates From the Advisory Committee on Immunization Practices: New Recommendations | MDedge
FY2025 EPS Estimates for Moderna Decreased by Analyst
Analyzing Aligos Therapeutics (NASDAQ:ALGS) and Moderna (NASDAQ:MRNA)
Moderna (NASDAQ:MRNA) Shares Down 5% – Time to Sell?
Berenberg Bank Initiates Coverage on Moderna (NASDAQ:MRNA)
Hsbc Global Res Upgrades Moderna (NASDAQ:MRNA) to Strong-Buy
Berenberg sees challenges for Moderna stock—downgrades and visibility issues persist By Investing.com
Moderna (NASDAQ:MRNA) Sees Strong Trading Volume - Here's What Happened
